BioSpace News Archive

Mirati Therapeutics, Inc., a clinical-stage targeted oncology company, announced that the company granted equity awards to 22 new employees with a grant date of October 3, 2022, as equity inducement awards outside of the company’s 2022 Equity Incentive Plan and material to the employees’ acceptance of employment with the company.

Biofrontera Inc. today announced preliminary unaudited product revenues for the three and nine months ended September 30, 2022.

BIOQUAL, Inc., Announces Promotion of Mr. Charles C. Kirk, Jr., CPA. to the Position of Chief Financial Officer.

Albireo Pharma, Inc. today announced the presentation of data at the American Association for the Study of Liver Diseases (AASLD) The Liver Meeting® 2022, being held November 4 – 8, 2022 in Washington, D.C.

ChemoCentryx, Inc., (Nasdaq: CCXI), today announced two upcoming poster presentations for CCX559, the Company’s investigational, highly potent, orally administered PD-L1 checkpoint inhibitor, at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting, held November 8-12, 2022, in Boston, MA.

Palleon Pharmaceuticals announced that the company’s scientific co-founder Carolyn Bertozzi, Ph.D., has been awarded the 2022 Nobel Prize in Chemistry.

Oxford Biomedica Solutions LLC, an Oxford Biomedica company that offers an end-to-end, full solution platform approach to the development and production of Adeno-Associated Virus (AAV) vectors used in gene therapy, will be presenting a Company overview and providing updates on its industry leading capabilities at upcoming Industry conferences.

WishBone Medical, Inc., a leader in pediatric orthopedic medical devices, is pleased to announce the appointment of John Herzenberg, MD, FRCSC, FAAOS, to its board of directors.

Cellecta, Inc. announced the launch of the DriverMap™ Adaptive Immune Receptor TCR and BCR kits, a family of multiplex-PCR, NGS-based assays that enable profiling of up to all seven T-cell receptor and B-cell receptor chains from the same sample, in a single tube, without need of specialized equipment.

SYNERGEN Health has been recognized in five categories in the 2022 Great Place to Work® program for its continued commitment to its employees and evolving workplace.